Home > Oncology > Study helps gauge long-term risks for women with DCIS by treatment

Study helps gauge long-term risks for women with DCIS by treatment


Notice: Undefined index: new_doi_fields in /home/daan/projects/medicalconferences_dev/wp-content/themes/writers-blogily-child/template-parts/content-structured.php on line 22

Notice: Trying to access array offset on value of type null in /home/daan/projects/medicalconferences_dev/wp-content/themes/writers-blogily-child/template-parts/content-structured.php on line 22

Notice: Trying to access array offset on value of type null in /home/daan/projects/medicalconferences_dev/wp-content/themes/writers-blogily-child/template-parts/content-structured.php on line 22
Conference
European Breast Cancer Conference 2020
Reuters Health - 07/10/2020 - New research helps clarify the long-term risk for invasive breast cancer in women with ductal carcinoma in situ (DCIS) who opt for breast-conserving surgery alone or with radiotherapy. The study suggests that surgery for DCIS followed by radiotherapy reduces the odds of cancer initially but this benefit diminishes over time, compared with surgery alone. The findings were presented October 3 during the 12th European Breast Cancer Conference (EBCC12) by Dr. Maartje van Seijen of the Netherlands Cancer Institute in Amsterdam. "Most women who are diagnosed with DCIS are offered surgery to remove the abnormal breast tissue and they are often also offered radiotherapy, even though the majority would not go on to develop invasive breast cancer. We wanted to look at how this group of women get on in the long term, according to which treatment they received," Dr. van Seijen explains in a conference statement. The study included mor...


Please login to read the full text of the article.


If you have no account yet, please register now.





Posted on